Double Blind Randomized Controlled Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength of These Muscles During Locomotion in Chronic Hemiparetic Patients.

Trial Profile

Double Blind Randomized Controlled Study of the Effect of Botulinum Toxin Injection in Rectus Femoris and Triceps on the Length and the Strength of These Muscles During Locomotion in Chronic Hemiparetic Patients.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Paresis
  • Focus Registrational; Therapeutic Use
  • Acronyms FOLOTOX
  • Most Recent Events

    • 12 Oct 2017 Planned End Date changed from 1 Sep 2017 to 30 May 2018.
    • 12 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 30 May 2018.
    • 10 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 Sep 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top